{"id":77075,"date":"2026-11-12T20:18:09","date_gmt":"2026-11-12T20:18:09","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=77075"},"modified":"2026-11-12T20:18:09","modified_gmt":"2026-11-12T20:18:09","slug":"american-analyst-updates-nov-12th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/","title":{"rendered":"American Analyst Updates: Nov 12th, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/strong><\/a><\/h2>\n

American analyst outlook on November 12th remains mixed and increasingly cautious, with widespread downgrades and price-target reductions across artificial intelligence, semiconductors, energy and consumer-related stocks reflecting concerns about elevated valuations, slowing earnings growth and profitability. Significant downgrades for NVIDIA highlight growing uncertainty surrounding AI investment returns, while positive revisions for AMD, Alibaba, select industrial companies and biotechnology stocks suggest continued confidence in long-term growth opportunities.<\/p>\n

Updates (296)<\/strong><\/h3>\n

3M (MMM)<\/strong> \u2014 Wolfe Research downgrades the stock from Outperform to Peer Perform.<\/p>\n

908 Devices (MASS)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and raises its price target to $14.00 from $13.50.<\/p>\n

Advance Auto Parts (AAP)<\/strong> \u2014 DA Davidson maintains its Neutral rating with a price target of $48.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Barclays changes its rating from Underweight to Overweight.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Bernstein downgrades the stock from Outperform to Market Perform.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Bank of America maintains its Buy rating and raises its price target to $700.00 from $650.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 BTIG Research initiates coverage with a Buy rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Citigroup downgrades the stock from Buy to Underperform.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 H.C. Wainwright initiates coverage with a Buy rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 KeyBanc downgrades the stock from Overweight to Sector Weight.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Piper Sandler downgrades the stock from Overweight to Neutral.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Roth Capital initiates coverage with a Buy rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 RBC Capital Markets maintains its Sector Perform rating with a price target of $540.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 William Blair upgrades the stock from Market Perform to Outperform.<\/p>\n

AEVEX Corp. (AVEX)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $30.00 from $45.00.<\/p>\n

AEVEX Corp. (AVEX)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and raises its price target to $15.00 from $13.00.<\/p>\n

Affiliated Managers Group (AMG)<\/strong> \u2014 Barrington Research maintains its Outperform rating and raises its price target to $455.00 from $425.00.<\/p>\n

Aflac (AFL)<\/strong> \u2014 Mizuho maintains its Underperform rating and raises its price target to $117.00 from $112.00.<\/p>\n

Aflac (AFL)<\/strong> \u2014 Wells Fargo maintains its Equal Weight rating and raises its price target to $124.00 from $116.00.<\/p>\n

AGI Inc (AGBK)<\/strong> \u2014 Oppenheimer maintains its Outperform rating and lowers its price target to $8.00 from $9.00.<\/p>\n

Agility Robotics (AGLT)<\/strong> \u2014 JPMorgan initiates coverage with a Neutral rating and a price target of $11.00.<\/p>\n

Airgain (AIRG)<\/strong> \u2014 Northland Securities downgrades the stock from Outperform to Market Perform with a price target of $4.50.<\/p>\n

Airgain (AIRG)<\/strong> \u2014 Northland Capital downgrades the stock from Outperform to Market Perform with a price target of $4.50.<\/p>\n

Alibaba Group (BABA)<\/strong> \u2014 DZ Bank upgrades the stock from Hold to Buy with a price target of $140.00.<\/p>\n

Allegiant Travel (ALGT)<\/strong> \u2014 UBS maintains its Buy rating and raises its price target to $120.00 from $107.00.<\/p>\n

Alliance Laundry (ALH)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $28.00 from $26.00.<\/p>\n

Allstate (ALL)<\/strong> \u2014 Raymond James reiterates its Strong-Buy rating.<\/p>\n

Alpha Cognition (ACOG)<\/strong> \u2014 Raymond James maintains its Outperform rating with a price target of $21.00.<\/p>\n

Alto Neuroscience (ANRO)<\/strong> \u2014 H.C. Wainwright reiterates its Buy rating.<\/p>\n

Amer Sports (AS)<\/strong> \u2014 BTIG Research maintains its Buy rating with a price target of $42.00.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Argus maintains its Buy rating and raises its price target to $515.00 from $460.00.<\/p>\n

Amplitude (AMPL)<\/strong> \u2014 BTIG Research maintains its Buy rating with a price target of $19.00.<\/p>\n

Amprius Technologies (AMPX)<\/strong> \u2014 B. Riley Securities maintains its Buy rating and lowers its price target to $16.00 from $22.00.<\/p>\n

Amprius Technologies (AMPX)<\/strong> \u2014 H.C. Wainwright reiterates its Buy rating.<\/p>\n

Anterix (ATEX)<\/strong> \u2014 B. Riley Securities upgrades the stock from Neutral to Buy and changes its price target to $103.00 from $86.00.<\/p>\n

APA Corporation (APA)<\/strong> \u2014 Bernstein maintains its Market Perform rating and raises its price target to $41.00 from $37.00.<\/p>\n

Apple (AAPL)<\/strong> \u2014 KeyBanc reiterates its Underweight rating.<\/p>\n

Applied Aerospace & Defense (AADX)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $17.00 from $16.00.<\/p>\n

Applied Aerospace & Defense (AADX)<\/strong> \u2014 RBC Capital Markets maintains its Outperform rating and lowers its price target to $15.00 from $18.00.<\/p>\n

Applied Aerospace & Defense (AADX)<\/strong> \u2014 Stifel maintains its Buy rating and lowers its price target to $18.00 from $24.00.<\/p>\n

Atlanta Braves (BATRK)<\/strong> \u2014 Rosenblatt Securities maintains its Buy rating and raises its price target to $91.00 from $73.00.<\/p>\n

Atlanticus (ATLC)<\/strong> \u2014 B. Riley Securities maintains its Buy rating and raises its price target to $125.00 from $119.00.<\/p>\n

Aveanna Healthcare (AVAH)<\/strong> \u2014 Raymond James reiterates its Strong-Buy rating.<\/p>\n

Avita Medical (RCEL)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $22.00 from $20.00.<\/p>\n

Best Buy (BBY)<\/strong> \u2014 Cfra downgrades the stock from Hold to Sell with a price target of $87.00.<\/p>\n

Bit Digital (BTBT)<\/strong> \u2014 H.C. Wainwright maintains its Buy rating and lowers its price target to $3.50 from $4.00.<\/p>\n

Boost Run (BRUN)<\/strong> \u2014 BTIG Research maintains its Buy rating with a price target of $25.00.<\/p>\n

Boyd Group Services (BGSI)<\/strong> \u2014 Mizuho maintains its Outperform rating and lowers its price target to $115.00 from $120.00.<\/p>\n

BrightView (BV)<\/strong> \u2014 JPMorgan maintains its Neutral rating and lowers its price target to $11.00 from $12.00.<\/p>\n

BrightView (BV)<\/strong> \u2014 Goldman Sachs maintains its Sell rating and lowers its price target to $8.70 from $10.00.<\/p>\n

Buckle (BKE)<\/strong> \u2014 UBS maintains its Neutral rating and lowers its price target to $45.00 from $46.00.<\/p>\n

Burford Capital (BUR)<\/strong> \u2014 Wedbush maintains its Neutral rating with a price target of $3.25.<\/p>\n

Capri (CPRI)<\/strong> \u2014 Jefferies maintains its Hold rating with a price target of $18.00.<\/p>\n

Cardinal Health (CAH)<\/strong> \u2014 Argus maintains its Buy rating and raises its price target to $309.00 from $264.00.<\/p>\n

Cardinal Infrastructure Group (CDNL)<\/strong> \u2014 William Blair downgrades the stock from Outperform to Market Perform.<\/p>\n

Carlisle Companies (CSL)<\/strong> \u2014 Northcoast Research initiates coverage with a Buy rating and a price target of $470.00.<\/p>\n

Cars.com (CARS)<\/strong> \u2014 Barclays initiates coverage with a Equal Weight rating and a price target of $14.00.<\/p>\n

Chagee (CHA)<\/strong> \u2014 Jefferies reiterates its Buy rating.<\/p>\n

Chevron (CVX)<\/strong> \u2014 Bernstein maintains its Market Perform rating and lowers its price target to $233.00 from $248.00.<\/p>\n

CI&T (CINT)<\/strong> \u2014 UBS maintains its Buy rating and raises its price target to $6.30 from $6.20.<\/p>\n

CI&T (CINT)<\/strong> \u2014 Wedbush reiterates its Neutral rating.<\/p>\n

Cigna Group (CI)<\/strong> \u2014 Jefferies maintains its Hold rating and raises its price target to $304.00 from $288.00.<\/p>\n

Cigna Group (CI)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and lowers its price target to $360.00 from $370.00.<\/p>\n

Cleveland-Cliffs (CLF)<\/strong> \u2014 Barclays upgrades the stock from Underweight to Equal Weight and changes its price target to $15.00 from $12.00.<\/p>\n

Cohu (COHU)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating with a price target of $65.00.<\/p>\n

Coinbase Global (COIN)<\/strong> \u2014 B. Riley Securities maintains its Neutral rating and lowers its price target to $150.00 from $203.00.<\/p>\n

Coincheck Group (CNCK)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and lowers its price target to $1.80 from $2.50.<\/p>\n

Compugen (CGEN)<\/strong> \u2014 H.C. Wainwright reiterates its Buy rating.<\/p>\n

ConocoPhillips (COP)<\/strong> \u2014 Bernstein downgrades the stock from Outperform to Market Perform with a price target of $122.00.<\/p>\n

Corbus Pharmaceuticals (CRBP)<\/strong> \u2014 Mizuho maintains its Outperform rating and lowers its price target to $23.00 from $24.00.<\/p>\n

Core & Main (CNM)<\/strong> \u2014 Jefferies maintains its Buy rating with a price target of $55.00.<\/p>\n

Corebridge Financial (CRBG)<\/strong> \u2014 Wells Fargo maintains its Overweight rating and raises its price target to $41.00 from $40.00.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Argus maintains its Buy rating and lowers its price target to $100.00 from $150.00.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Barclays maintains its Equal Weight rating and lowers its price target to $85.00 from $105.00.<\/p>\n

Corteva (CTVA)<\/strong> \u2014 Mizuho sets a price target of $16.00.<\/p>\n

Coty (COTY)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $4.50 from $3.00.<\/p>\n

Coya Therapeutics (COYA)<\/strong> \u2014 H.C. Wainwright maintains its Buy rating with a price target of $18.00.<\/p>\n

CubeSmart (CUBE)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $49.00 from $41.00.<\/p>\n

CuriosityStream (CURI)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $4.00 from $6.00.<\/p>\n

Cushman & Wakefield (CWK)<\/strong> \u2014 Jefferies reiterates its Hold rating.<\/p>\n

Cushman & Wakefield (CWK)<\/strong> \u2014 Goldman Sachs maintains its Buy rating and raises its price target to $19.00 from $17.00.<\/p>\n

Customers Bancorp (CUBI)<\/strong> \u2014 B. Riley Securities maintains its Buy rating and raises its price target to $110.00 from $104.00.<\/p>\n

CVS Health (CVS)<\/strong> \u2014 Wells Fargo maintains its Overweight rating and lowers its price target to $112.00 from $123.00.<\/p>\n

CytomX Therapeutics (CTMX)<\/strong> \u2014 JPMorgan maintains its Overweight rating and raises its price target to $12.00 from $11.00.<\/p>\n

Delek Logistics Partners (DKL)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $56.00 from $52.00.<\/p>\n

Devon Energy (DVN)<\/strong> \u2014 Bernstein downgrades the stock from Outperform to Market Perform with a price target of $44.00.<\/p>\n

Diamondback Energy (FANG)<\/strong> \u2014 Bernstein downgrades the stock from Outperform to Market Perform with a price target of $192.00.<\/p>\n

Diebold Nixdorf (DBD)<\/strong> \u2014 DA Davidson maintains its Buy rating with a price target of $80.00.<\/p>\n

Digi International (DGII)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and lowers its price target to $67.00 from $76.00.<\/p>\n

Dorman Products (DORM)<\/strong> \u2014 Barclays initiates coverage with a Overweight rating and a price target of $165.00.<\/p>\n

DoubleDown Interactive (DDI)<\/strong> \u2014 Canadian Imperial Bank of Commerce sets a price target of $16.25.<\/p>\n

DoubleDown Interactive (DDI)<\/strong> \u2014 Macquarie downgrades the stock from Outperform to Neutral with a price target of $16.25.<\/p>\n

DoubleDown Interactive (DDI)<\/strong> \u2014 Roth Capital downgrades the stock from Buy to Neutral and changes its price target to $16.25 from $16.00.<\/p>\n

DoubleDown Interactive (DDI)<\/strong> \u2014 Wedbush maintains its Outperform rating with a price target of $16.25.<\/p>\n

Douglas Elliman (DOUG)<\/strong> \u2014 Citigroup reiterates its Market Perform rating.<\/p>\n

Edgewell Personal Care (EPC)<\/strong> \u2014 Raymond James reiterates its Market Perform rating.<\/p>\n

Elastic (ESTC)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $132.00 from $128.00.<\/p>\n

Elemental Royalty (ELE)<\/strong> \u2014 H.C. Wainwright maintains its Buy rating and lowers its price target to $30.25 from $31.00.<\/p>\n

Emerson Electric (EMR)<\/strong> \u2014 DA Davidson maintains its Neutral rating and raises its price target to $160.00 from $155.00.<\/p>\n

Enersys (ENS)<\/strong> \u2014 BTIG Research maintains its Buy rating and lowers its price target to $250.00 from $280.00.<\/p>\n

enGene (ENGN)<\/strong> \u2014 Piper Sandler upgrades the stock from Neutral to Overweight with a price target of $4.00.<\/p>\n

enGene (ENGN)<\/strong> \u2014 Raymond James reiterates its Outperform rating.<\/p>\n

enGene (ENGN)<\/strong> \u2014 UBS reiterates its Outperform rating.<\/p>\n

enGene (ENGN)<\/strong> \u2014 Wells Fargo upgrades the stock from Equal Weight to Overweight and changes its price target to $6.00 from $2.00.<\/p>\n

Ensysce Biosciences (ENSC)<\/strong> \u2014 UBS initiates coverage with a Buy rating and a price target of $2.00.<\/p>\n

Equitable (EQH)<\/strong> \u2014 Wells Fargo maintains its Overweight rating and raises its price target to $67.00 from $65.00.<\/p>\n

Essent Group (ESNT)<\/strong> \u2014 JPMorgan maintains its Neutral rating and raises its price target to $67.00 from $66.00.<\/p>\n

eToro Group (ETOR)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $37.00 from $48.00.<\/p>\n

eToro Group (ETOR)<\/strong> \u2014 Susquehanna maintains its Positive rating and lowers its price target to $39.00 from $46.00.<\/p>\n

eToro Group (ETOR)<\/strong> \u2014 UBS maintains its Neutral rating and lowers its price target to $26.00 from $35.00.<\/p>\n

Everpure (P)<\/strong> \u2014 UBS maintains its Sell rating and raises its price target to $88.00 from $80.00.<\/p>\n

EVgo (EVGO)<\/strong> \u2014 Stifel downgrades the stock from Buy to Hold and changes its price target to $2.50 from $6.00.<\/p>\n

Expand Energy (EXE)<\/strong> \u2014 Bernstein maintains its Outperform rating and lowers its price target to $136.00 from $139.00.<\/p>\n

Extra Space Storage (EXR)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $172.00 from $147.00.<\/p>\n

ExxonMobil (XOM)<\/strong> \u2014 Bernstein maintains its Outperform rating and lowers its price target to $186.00 from $193.00.<\/p>\n

EZCORP, Inc. (EZPW)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n

Fervo Energy (FRVO)<\/strong> \u2014 Bank of America maintains its Buy rating and lowers its price target to $25.00 from $30.00.<\/p>\n

Fidelity National Information Services (FIS)<\/strong> \u2014 Truist Financial maintains its Hold rating and lowers its price target to $31.00 from $37.00.<\/p>\n

Flex (FLEX)<\/strong> \u2014 KeyBanc maintains its Overweight rating and lowers its price target to $128.00 from $180.00.<\/p>\n

Flex LNG (FLNG)<\/strong> \u2014 BTIG Research reiterates its Neutral rating.<\/p>\n

Franco-Nevada (FNV)<\/strong> \u2014 H.C. Wainwright maintains its Buy rating with a price target of $305.00.<\/p>\n

General Mills (GIS)<\/strong> \u2014 Piper Sandler downgrades the stock from Overweight to Neutral and changes its price target to $35.00 from $41.00.<\/p>\n

Gilead Sciences (GILD)<\/strong> \u2014 Argus sets a price target of $190.00.<\/p>\n

GitLab (GTLB)<\/strong> \u2014 Mizuho maintains its Neutral rating and raises its price target to $51.00 from $47.00.<\/p>\n

Global-e Online (GLBE)<\/strong> \u2014 BMO Capital Markets maintains its Outperform rating and raises its price target to $51.00 from $48.00.<\/p>\n

Globe Life (GL)<\/strong> \u2014 Raymond James maintains its Strong-Buy rating with a price target of $208.00.<\/p>\n

Grocery Outlet (GO)<\/strong> \u2014 DA Davidson maintains its Neutral rating and raises its price target to $14.00 from $12.00.<\/p>\n

Grocery Outlet (GO)<\/strong> \u2014 Goldman Sachs maintains its Sell rating and raises its price target to $8.00 from $6.00.<\/p>\n

GXO Logistics (GXO)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $75.00 from $65.00.<\/p>\n

Harmony Biosciences (HRMY)<\/strong> \u2014 H.C. Wainwright maintains its Buy rating with a price target of $55.00.<\/p>\n

HIVE Digital Technologies (HIVE)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $6.00 from $10.00.<\/p>\n

HIVE Digital Technologies (HIVE)<\/strong> \u2014 Rosenblatt Securities maintains its Buy rating and lowers its price target to $5.00 from $6.00.<\/p>\n

Humana (HUM)<\/strong> \u2014 Wells Fargo maintains its Overweight rating and raises its price target to $602.00 from $502.00.<\/p>\n

iHeartMedia (IHRT)<\/strong> \u2014 Bank of America downgrades the stock from Neutral to Underperform with a price target of $1.00.<\/p>\n

Inhibikase Therapeutics (IKT)<\/strong> \u2014 H.C. Wainwright maintains its Buy rating with a price target of $8.00.<\/p>\n

InMode (INMD)<\/strong> \u2014 Robert W. Baird maintains its Neutral rating and lowers its price target to $15.00 from $17.00.<\/p>\n

Innoviz Technologies (INVZ)<\/strong> \u2014 JPMorgan downgrades the stock from Overweight to Neutral.<\/p>\n

Inovio Pharmaceuticals (INO)<\/strong> \u2014 H.C. Wainwright maintains its Buy rating with a price target of $5.00.<\/p>\n

Installed Building Products (IBP)<\/strong> \u2014 StoneX upgrades the stock from Hold to Buy with a price target of $275.00.<\/p>\n

Intel (INTC)<\/strong> \u2014 Bank of America maintains its Neutral rating and lowers its price target to $80.00 from $100.00.<\/p>\n

International Money Express (IMXI)<\/strong> \u2014 UBS maintains its Neutral rating and lowers its price target to $7.00 from $16.00.<\/p>\n

Jack Henry & Associates (JKHY)<\/strong> \u2014 Benchmark reiterates its Overweight rating.<\/p>\n

Jack Henry & Associates (JKHY)<\/strong> \u2014 Piper Sandler reiterates its Overweight rating.<\/p>\n

Janux Therapeutics (JANX)<\/strong> \u2014 Citigroup reiterates its Buy rating.<\/p>\n

Janux Therapeutics (JANX)<\/strong> \u2014 H.C. Wainwright reiterates its Buy rating.<\/p>\n

Janux Therapeutics (JANX)<\/strong> \u2014 Wolfe Research downgrades the stock from Outperform to Peer Perform.<\/p>\n

Jazz Pharmaceuticals (JAZZ)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $330.00 from $310.00.<\/p>\n

JFrog (FROG)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $114.00 from $100.00.<\/p>\n

Jones Lang LaSalle (JLL)<\/strong> \u2014 Jefferies maintains its Buy rating with a price target of $438.00.<\/p>\n

Kennametal (KMT)<\/strong> \u2014 DA Davidson maintains its Neutral rating and lowers its price target to $25.00 from $30.00.<\/p>\n

Kimball Electronics (KE)<\/strong> \u2014 Roth Capital initiates coverage with a Buy rating and a price target of $37.00.<\/p>\n

Kodiak Gas Services (KGS)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $75.00 from $82.00.<\/p>\n

Kopin (KOPN)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and raises its price target to $7.50 from $6.50.<\/p>\n

Kosmos Energy (KOS)<\/strong> \u2014 Bernstein maintains its Market Perform rating and raises its price target to $2.00 from $1.90.<\/p>\n

Kura Oncology (KURA)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n

Kura Oncology (KURA)<\/strong> \u2014 UBS sets a price target of $24.00.<\/p>\n

Lakefront Biotherapeutics American Depositary Shares (LKFT)<\/strong> \u2014 Raymond James reiterates its Market Perform rating.<\/p>\n

Lexeo Therapeutics (LXEO)<\/strong> \u2014 Cantor Fitzgerald reiterates its Overweight rating.<\/p>\n

Liberty Global (LILAK)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $11.00 from $9.00.<\/p>\n

LifeStance Health Group (LFST)<\/strong> \u2014 JPMorgan maintains its Neutral rating and raises its price target to $15.00 from $13.00.<\/p>\n

Lincoln National (LNC)<\/strong> \u2014 Wells Fargo maintains its Overweight rating and lowers its price target to $53.00 from $54.00.<\/p>\n

Live Nation Entertainment (LYV)<\/strong> \u2014 BTIG Research reiterates its Buy rating.<\/p>\n

M\/I Homes (MHO)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n

M\/I Homes (MHO)<\/strong> \u2014 UBS sets a price target of $165.00.<\/p>\n

Madrigal Pharmaceuticals (MDGL)<\/strong> \u2014 H.C. Wainwright reiterates its Buy rating.<\/p>\n

Maravai LifeSciences (MRVI)<\/strong> \u2014 KeyBanc upgrades the stock from Sector Weight to Overweight with a price target of $11.00.<\/p>\n

Martin Marietta Materials (MLM)<\/strong> \u2014 UBS maintains its Buy rating and lowers its price target to $640.00 from $662.00.<\/p>\n

Matador Resources (MTDR)<\/strong> \u2014 UBS maintains its Neutral rating and lowers its price target to $62.00 from $64.00.<\/p>\n

Matador Resources (MTDR)<\/strong> \u2014 Wells Fargo maintains its Overweight rating and lowers its price target to $71.00 from $72.00.<\/p>\n

MBX Biosciences (MBX)<\/strong> \u2014 H.C. Wainwright initiates coverage with a Buy rating and a price target of $90.00.<\/p>\n

McGrath RentCorp (MGRC)<\/strong> \u2014 Oppenheimer maintains its Outperform rating and raises its price target to $149.00 from $143.00.<\/p>\n

MDU Resources Group (MDU)<\/strong> \u2014 Freedom Broker upgrades the stock from Hold to Buy and changes its price target to $23.00 from $21.00.<\/p>\n

Melco Resorts & Entertainment (MLCO)<\/strong> \u2014 UBS downgrades the stock from Buy to Sell with a price target of $3.70.<\/p>\n

Mercury Systems (MRCY)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and raises its price target to $129.00 from $128.00.<\/p>\n

MetLife (MET)<\/strong> \u2014 Mizuho maintains its Outperform rating and raises its price target to $117.00 from $112.00.<\/p>\n

MetLife (MET)<\/strong> \u2014 Wells Fargo maintains its Overweight rating and raises its price target to $113.00 from $110.00.<\/p>\n

MFA Financial (MFA)<\/strong> \u2014 RBC Capital Markets maintains its Sector Perform rating and lowers its price target to $7.00 from $10.00.<\/p>\n

Mid Penn Bancorp (MPB)<\/strong> \u2014 Raymond James upgrades the stock from Outperform to Strong-Buy and changes its price target to $42.00 from $39.00.<\/p>\n

Monopar Therapeutics (MNPR)<\/strong> \u2014 Cantor Fitzgerald upgrades the stock from Neutral to Overweight with a price target of $119.00.<\/p>\n

MoonLake Immunotherapeutics (MLTX)<\/strong> \u2014 Wedbush maintains its Outperform rating with a price target of $34.00.<\/p>\n

Mosaic (MOS)<\/strong> \u2014 KeyBanc reiterates its Sector Weight rating.<\/p>\n

Myriad Genetics (MYGN)<\/strong> \u2014 Stephens reiterates its Outperform rating.<\/p>\n

Nayax (NYAX)<\/strong> \u2014 Barclays maintains its Equal Weight rating and lowers its price target to $60.00 from $68.00.<\/p>\n

Nayax (NYAX)<\/strong> \u2014 UBS maintains its Neutral rating and lowers its price target to $66.00 from $70.00.<\/p>\n

Netskope (NTSK)<\/strong> \u2014 Mizuho maintains its Neutral rating and raises its price target to $19.00 from $16.00.<\/p>\n

Nexa Resources (NEXA)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $12.00 from $14.00.<\/p>\n

Nextpower (NXT)<\/strong> \u2014 RBC Capital Markets maintains its Outperform rating and raises its price target to $120.00 from $116.00.<\/p>\n

NIQ Global Intelligence (NIQ)<\/strong> \u2014 BMO Capital Markets maintains its Outperform rating with a price target of $22.00.<\/p>\n

Novanta (NOVT)<\/strong> \u2014 Robert W. Baird maintains its Outperform rating and lowers its price target to $175.00 from $194.00.<\/p>\n

Nucor (NUE)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $345.00 from $320.00.<\/p>\n

Nutrien (NTR)<\/strong> \u2014 UBS maintains its Sell rating and raises its price target to $63.00 from $62.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Bernstein downgrades the stock from Outperform to Market Perform and changes its price target to $200.00 from $400.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 BMO Capital Markets maintains its Outperform rating and lowers its price target to $240.00 from $340.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Bank of America maintains its Buy rating and lowers its price target to $280.00 from $350.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $250.00 from $350.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Craig Hallum downgrades the stock from Buy to Hold with a price target of $180.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 DA Davidson maintains its Buy rating and lowers its price target to $200.00 from $300.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Evercore ISI downgrades the stock from Outperform to In-line with a price target of $186.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 KeyBanc downgrades the stock from Overweight to Sector Weight.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Melius Research downgrades the stock from Buy to Hold and changes its price target to $185.00 from $315.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and lowers its price target to $200.00 from $300.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 New Street Research reiterates its Buy rating.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Oppenheimer downgrades the stock from Outperform to Market Perform.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 RBC Capital Markets sets a price target of $225.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Stifel maintains its Buy rating and lowers its price target to $205.00 from $315.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 StoneX downgrades the stock from Buy to Hold.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Truist Financial downgrades the stock from Buy to Hold with a price target of $174.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 Wedbush maintains its Outperform rating with a price target of $345.00.<\/p>\n

NVIDIA (NVDA)<\/strong> \u2014 William Blair downgrades the stock from Outperform to Market Perform.<\/p>\n

Occidental Petroleum (OXY)<\/strong> \u2014 Susquehanna reiterates its Positive rating.<\/p>\n

ODDITY Tech (ODD)<\/strong> \u2014 Barclays maintains its Underweight rating and raises its price target to $15.00 from $12.00.<\/p>\n

ODDITY Tech (ODD)<\/strong> \u2014 Needham & Company LLC reiterates its Hold rating.<\/p>\n

ODDITY Tech (ODD)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $20.00 from $18.00.<\/p>\n

OptimizeRx (OPRX)<\/strong> \u2014 B. Riley Securities maintains its Buy rating and lowers its price target to $10.50 from $11.00.<\/p>\n

OptimizeRx (OPRX)<\/strong> \u2014 Lake Street Capital maintains its Buy rating and lowers its price target to $10.00 from $11.00.<\/p>\n

OptimizeRx (OPRX)<\/strong> \u2014 Stifel maintains its Buy rating and lowers its price target to $11.00 from $12.00.<\/p>\n

Palmer Square Capital BDC (PSBD)<\/strong> \u2014 RBC Capital Markets maintains its Sector Perform rating and lowers its price target to $10.00 from $11.00.<\/p>\n

Palo Alto Networks (PANW)<\/strong> \u2014 Jefferies maintains its Buy rating and lowers its price target to $400.00 from $450.00.<\/p>\n

Pattern Group (PTRN)<\/strong> \u2014 Jefferies upgrades the stock from Hold to Buy and changes its price target to $27.00 from $20.00.<\/p>\n

PennyMac Financial Services (PFSI)<\/strong> \u2014 BTIG Research maintains its Buy rating with a price target of $80.00.<\/p>\n

PennyMac Mortgage Investment Trust (PMT)<\/strong> \u2014 BTIG Research reiterates its Neutral rating.<\/p>\n

Permian Resources (PR)<\/strong> \u2014 Wells Fargo maintains its Overweight rating and raises its price target to $28.00 from $27.00.<\/p>\n

Pfizer (PFE)<\/strong> \u2014 Bernstein reiterates its Market Perform rating.<\/p>\n

PolyPid (PYPD)<\/strong> \u2014 H.C. Wainwright maintains its Buy rating with a price target of $13.00.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 Mizuho maintains its Neutral rating and raises its price target to $120.00 from $116.00.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 Wells Fargo maintains its Underweight rating and raises its price target to $113.00 from $103.00.<\/p>\n

PTC Inc. (PTC)<\/strong> \u2014 Wolfe Research downgrades the stock from Outperform to Peer Perform.<\/p>\n

Public Storage (PSA)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $365.00 from $317.00.<\/p>\n

Quantinuum (QNT)<\/strong> \u2014 BTIG Research initiates coverage with a Buy rating and a price target of $60.00.<\/p>\n

Quantum-Si (QSI)<\/strong> \u2014 H.C. Wainwright reiterates its Buy rating.<\/p>\n

Quantum-Si (QSI)<\/strong> \u2014 UBS reiterates its Buy rating.<\/p>\n

QXO, Inc. (QXO)<\/strong> \u2014 Northcoast Research initiates coverage with a Neutral rating.<\/p>\n

Ready Capital (RC)<\/strong> \u2014 UBS maintains its Neutral rating and lowers its price target to $1.25 from $2.00.<\/p>\n

Reddit (RDDT)<\/strong> \u2014 Argus maintains its Buy rating and lowers its price target to $150.00 from $225.00.<\/p>\n

Redwood Trust (RWT)<\/strong> \u2014 Keefe Bruyette downgrades the stock from Outperform to Market Perform with a price target of $3.50.<\/p>\n

Redwood Trust (RWT)<\/strong> \u2014 Keefe, Bruyette & Woods downgrades the stock from Outperform to Market Perform and changes its price target to $3.50 from $4.25.<\/p>\n

Reformation (REF)<\/strong> \u2014 JPMorgan maintains its Overweight rating and raises its price target to $26.00 from $21.00.<\/p>\n

Reinsurance Group of America (RGA)<\/strong> \u2014 Wells Fargo maintains its Overweight rating and raises its price target to $312.00 from $292.00.<\/p>\n

Reliance (RS)<\/strong> \u2014 Barclays upgrades the stock from Equal Weight to Overweight and changes its price target to $507.00 from $445.00.<\/p>\n

Republic Services (RSG)<\/strong> \u2014 Argus upgrades the stock from Hold to Buy with a price target of $275.00.<\/p>\n

Resideo Technologies (REZI)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n

Resideo Technologies (REZI)<\/strong> \u2014 Citizens Jmp maintains its Market Outperform rating and raises its price target to $29.00 from $22.00.<\/p>\n

Resideo Technologies (REZI)<\/strong> \u2014 UBS sets a price target of $29.00.<\/p>\n

Revvity (RVTY)<\/strong> \u2014 Bernstein reiterates its Market Perform rating.<\/p>\n

Riskified (RSKD)<\/strong> \u2014 DA Davidson maintains its Buy rating and raises its price target to $12.00 from $9.00.<\/p>\n

Riskified (RSKD)<\/strong> \u2014 Keefe, Bruyette & Woods reiterates its Market Perform rating.<\/p>\n

Riskified (RSKD)<\/strong> \u2014 UBS maintains its Neutral rating and raises its price target to $10.50 from $6.50.<\/p>\n

Rocket Lab (RKLB)<\/strong> \u2014 Berenberg Bank sets a price target of $85.00.<\/p>\n

Ross Stores (ROST)<\/strong> \u2014 UBS reiterates its Buy rating.<\/p>\n

Royal Caribbean Cruises (RCL)<\/strong> \u2014 Bank of America maintains its Buy rating with a price target of $365.00.<\/p>\n

Royal Caribbean Cruises (RCL)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $330.00 from $300.00.<\/p>\n

Rubrik (RBRK)<\/strong> \u2014 Mizuho maintains its Outperform rating and raises its price target to $125.00 from $112.00.<\/p>\n

SailPoint (SAIL)<\/strong> \u2014 Mizuho maintains its Neutral rating and raises its price target to $20.00 from $19.00.<\/p>\n

Savara (SVRA)<\/strong> \u2014 H.C. Wainwright initiates coverage with a Buy rating and a price target of $10.00.<\/p>\n

Scholar Rock (SRRK)<\/strong> \u2014 Wolfe Research downgrades the stock from Outperform to Peer Perform.<\/p>\n

Sea Limited Sponsored ADR (SE)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $150.00 from $156.00.<\/p>\n

Sea Limited Sponsored ADR (SE)<\/strong> \u2014 Bernstein reiterates its Outperform rating.<\/p>\n

Shift4 Payments (FOUR)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $43.00 from $42.00.<\/p>\n

Sight Sciences (SGHT)<\/strong> \u2014 UBS maintains its Buy rating and raises its price target to $13.50 from $8.00.<\/p>\n

Skyward Specialty Insurance Group (SKWD)<\/strong> \u2014 Raymond James maintains its Strong-Buy rating with a price target of $75.00.<\/p>\n

Smartstop Self Storage REIT (SMA)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $41.00 from $33.00.<\/p>\n

Solana (HSDT)<\/strong> \u2014 B. Riley Securities maintains its Buy rating and lowers its price target to $3.00 from $4.00.<\/p>\n

Spruce Biosciences (SPRB)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n

Spyglass Pharma (SGP)<\/strong> \u2014 H.C. Wainwright maintains its Buy rating and raises its price target to $43.00 from $37.00.<\/p>\n

Starwood Property Trust (STWD)<\/strong> \u2014 UBS maintains its Buy rating and lowers its price target to $16.00 from $20.00.<\/p>\n

Steel Dynamics (STLD)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $300.00 from $280.00.<\/p>\n

Structure Therapeutics (GPCR)<\/strong> \u2014 H.C. Wainwright reiterates its Buy rating.<\/p>\n

Sunrise Realty Trust (SUNS)<\/strong> \u2014 B. Riley Securities maintains its Buy rating and lowers its price target to $13.00 from $13.50.<\/p>\n

T1 Energy (TE)<\/strong> \u2014 BTIG Research maintains its Buy rating and lowers its price target to $7.00 from $9.00.<\/p>\n

Target (TGT)<\/strong> \u2014 Guggenheim maintains its Buy rating with a price target of $175.00.<\/p>\n

Target (TGT)<\/strong> \u2014 UBS maintains its Buy rating and raises its price target to $205.00 from $185.00.<\/p>\n

Teekay Tankers (TNK)<\/strong> \u2014 Bank of America maintains its Underperform rating and raises its price target to $83.00 from $78.00.<\/p>\n

Terreno Realty (TRNO)<\/strong> \u2014 Robert W. Baird maintains its Outperform rating and lowers its price target to $69.00 from $70.00.<\/p>\n

Terrestrial Energy (IMSR)<\/strong> \u2014 Wedbush maintains its Neutral rating with a price target of $4.00.<\/p>\n

Tetra Tech (TTEK)<\/strong> \u2014 Robert W. Baird maintains its Neutral rating and raises its price target to $40.00 from $37.00.<\/p>\n

Teva Pharmaceutical Industries (TEVA)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $56.00 from $44.00.<\/p>\n

The Hartford Insurance Group (HIG)<\/strong> \u2014 Mizuho maintains its Neutral rating and raises its price target to $145.00 from $144.00.<\/p>\n

Toyota Motor (TM)<\/strong> \u2014 Freedom Broker downgrades the stock from Buy to Hold with a price target of $230.00.<\/p>\n

Uniti Group (UNIT)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $5.00 from $11.75.<\/p>\n

Unum Group (UNM)<\/strong> \u2014 Wells Fargo maintains its Overweight rating and lowers its price target to $91.00 from $102.00.<\/p>\n

Valvoline (VVV)<\/strong> \u2014 Piper Sandler reiterates its Overweight rating.<\/p>\n

Victoria’s Secret & Co. (VSXY)<\/strong> \u2014 Bank of America downgrades the stock from Buy to Neutral and changes its price target to $112.00 from $95.00.<\/p>\n

Voya Financial (VOYA)<\/strong> \u2014 Wells Fargo maintains its Equal Weight rating and raises its price target to $106.00 from $102.00.<\/p>\n

Walmart (WMT)<\/strong> \u2014 BTIG Research maintains its Buy rating with a price target of $140.00.<\/p>\n

WAVE Life Sciences (WVE)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $15.00 from $19.00.<\/p>\n

Wayfair (W)<\/strong> \u2014 Argus maintains its Buy rating and raises its price target to $135.00 from $125.00.<\/p>\n

WBI (WBI)<\/strong> \u2014 Wells Fargo maintains its Equal Weight rating and raises its price target to $31.00 from $28.00.<\/p>\n

Wendy’s (WEN)<\/strong> \u2014 Northcoast Research upgrades the stock from Sell to Neutral.<\/p>\n

WhiteFiber (WYFI)<\/strong> \u2014 B. Riley Securities maintains its Buy rating and lowers its price target to $32.00 from $38.00.<\/p>\n

Williams-Sonoma (WSM)<\/strong> \u2014 UBS maintains its Neutral rating and raises its price target to $265.00 from $247.00.<\/p>\n

Wolverine World Wide (WWW)<\/strong> \u2014 Needham & Company LLC maintains its Buy rating and raises its price target to $26.00 from $24.00.<\/p>\n

Workday (WDAY)<\/strong> \u2014 Oppenheimer reiterates its Outperform rating.<\/p>\n

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (XNDU)<\/strong> \u2014 RBC Capital Markets maintains its Outperform rating with a price target of $13.00.<\/p>\n

XP Inc. (XP)<\/strong> \u2014 Goldman Sachs maintains its Buy rating and lowers its price target to $31.00 from $36.00.<\/p>\n

YETI Holdings, Inc. (YETI)<\/strong> \u2014 Raymond James reiterates its Outperform rating.<\/p>\n

Yum! Brands (YUM)<\/strong> \u2014 TD Cowen reiterates its Buy rating.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) American analyst outlook on November 12th remains mixed and increasingly cautious, with widespread downgrades and price-target reductions across artificial intelligence, semiconductors,…<\/p>\n","protected":false},"author":3,"featured_media":77078,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-77075","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nAmerican Analyst Updates: Nov 12th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Updates: Nov 12th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) American analyst outlook on November 12th remains mixed and increasingly cautious, with widespread downgrades and price-target reductions across artificial intelligence, semiconductors,…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-12T20:18:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/11\/Red-Accented-NVIDIA-AI-Accelerator-Board-1024x576.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"21 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"American Analyst Updates: Nov 12th, 2026\",\"datePublished\":\"2026-11-12T20:18:09+00:00\",\"dateModified\":\"2026-11-12T20:18:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/\"},\"wordCount\":4343,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/\",\"name\":\"American Analyst Updates: Nov 12th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-11-12T20:18:09+00:00\",\"dateModified\":\"2026-11-12T20:18:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Updates: Nov 12th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Updates: Nov 12th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Updates: Nov 12th, 2026","og_description":"Analyst Ratings (USA) American analyst outlook on November 12th remains mixed and increasingly cautious, with widespread downgrades and price-target reductions across artificial intelligence, semiconductors,…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-11-12T20:18:09+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/11\/Red-Accented-NVIDIA-AI-Accelerator-Board-1024x576.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"21 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"American Analyst Updates: Nov 12th, 2026","datePublished":"2026-11-12T20:18:09+00:00","dateModified":"2026-11-12T20:18:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/"},"wordCount":4343,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/","name":"American Analyst Updates: Nov 12th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-11-12T20:18:09+00:00","dateModified":"2026-11-12T20:18:09+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-12th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Updates: Nov 12th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/77075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=77075"}],"version-history":[{"count":1,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/77075\/revisions"}],"predecessor-version":[{"id":77077,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/77075\/revisions\/77077"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/77078"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=77075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=77075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=77075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}